Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase

被引:13
|
作者
Selness, Shaun R. [1 ]
Boehm, Terri L. [1 ]
Walker, John K. [1 ]
Devadas, Balekudru [1 ]
Durley, Richard C. [1 ]
Kurumbail, Ravi [2 ]
Shieh, Huey [2 ]
Xing, Li [2 ]
Hepperle, Michael [1 ]
Rucker, Paul V. [1 ]
Jerome, Kevin D. [1 ]
Benson, Alan G. [1 ]
Marrufo, Laura D. [1 ]
Madsen, Heather M. [1 ]
Hitchcock, Jeff [1 ]
Owen, Tom J. [1 ]
Christie, Lance [1 ]
Promo, Michele A. [1 ]
Hickory, Brian S. [1 ]
Alvira, Edgardo [1 ]
Naing, Win [1 ]
Blevis-Bal, Radhika [1 ]
Devraj, Rajesh V. [1 ]
Messing, Dean [3 ]
Schindler, John F. [4 ]
Hirsch, Jeffrey [4 ]
Saabye, Matthew [4 ]
Bonar, Sheri [4 ]
Webb, Elizabeth [4 ]
Anderson, Gary [4 ]
Monahan, Joseph B. [2 ,4 ]
机构
[1] Pfizer Corp, Dept Med Chem, Chesterfield, MO 63017 USA
[2] Pfizer Corp, Struct & Computat Chem, Chesterfield, MO 63017 USA
[3] Pfizer Corp, Dept Pharmcokinet & Drug Metab, Chesterfield, MO 63017 USA
[4] Pfizer Corp, Inflammat Biol, Chesterfield, MO 63017 USA
关键词
p38; kinase; Inflammation; Rheumatoid arthritis; TNF alpha; Pyridinones; RHEUMATOID-ARTHRITIS;
D O I
10.1016/j.bmcl.2011.04.120
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of N-aryl pyridinone inhibitors of p38 mitogen activated protein (MAP) kinase were designed and prepared based on the screening hit SC-25028 (1) and structural comparisons to VX-745 (5). The focus of the investigation targeted the dependence of potency and metabolic stability on the benzyloxy connectivity, the role of the C-6 position and the substitution pattern on the N-phenyl ring. Further optimization produced the highly selective and potent pyridinones 2 and 3. These inhibitors exhibited activity in both acute and chronic models of inflammation. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4059 / 4065
页数:7
相关论文
共 50 条
  • [41] MEDI 137-Pyrazolo-pyrimidines as selective and potent p38 inhibitors
    Moquin, Robert V.
    Das, Jagabandhu
    Schieven, Gary
    Pitt, Sidney
    Zhang, Rosemary
    Shen, Ding Ren
    McIntyre, Kim W.
    Gillooly, Kathleen M.
    Sack, Jack
    Doweyko, Arthur
    Zhang, Hongjian
    Kiefer, Susan E.
    Kish, Kevin
    Barrish, Joel
    Dodd, John H.
    Leftheris, Katerina
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [42] Discovery of Highly Selective and Potent p38 Inhibitors Based on a Phthalazine Scaffold
    Herberich, Brad
    Cao, Guo-Qiang
    Chakrabarti, Partha P.
    Falsey, James R.
    Pettus, Liping
    Rzasa, Robert M.
    Reed, Anthony B.
    Reichelt, Andreas
    Sham, Kelvin
    Thaman, Maya
    Wurz, Ryan P.
    Xu, Shimin
    Zhang, Dawei
    Hsieh, Faye
    Lee, Matthew R.
    Syed, Rashid
    Li, Vivian
    Grosfeld, David
    Plant, Matthew H.
    Henkle, Bradley
    Sherman, Lisa
    Middleton, Scot
    Wong, Lu Min
    Tasker, Andrew S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (20) : 6271 - 6279
  • [43] Substituted Benzamides from Anti-inflammatory and p38 Kinase Inhibitors to Antitubercular Activity: Design, Synthesis and Screening
    Kulkarni, Ravindra
    Mitkari, Umakant
    Achaiah, G.
    Laufer, Stefan
    Bikshapti, D. V. R. N.
    Chandrashekar, V. M.
    Gurav, P. B.
    Joshi, S. J.
    Chipade, V. D.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (17) : 1486 - 1497
  • [44] Synthesis and Biological Testing of N-Aminoimidazole-Based p38α MAP Kinase Inhibitors
    Bracht, Claudia
    Hauser, Dominik R. J.
    Schattel, Verena
    Albrecht, Wolfgang
    Laufer, Stefan A.
    CHEMMEDCHEM, 2010, 5 (07) : 1134 - 1142
  • [45] Design, Synthesis, and Biological Evaluation of Chromone-Based p38 MAP Kinase Inhibitors
    Dyrager, Christine
    Mollers, Linda Nilsson
    Kjall, Linda Karlsson
    Alao, John Patrick
    Diner, Peter
    Wallner, Fredrik K.
    Sunnerhagen, Per
    Grotli, Morten
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7427 - 7431
  • [46] Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase
    Hammach, Abdelhakim
    Barbosa, Antonio
    Gaenzler, Faith Corbo
    Fadra, Tazmeen
    Goldberg, Daniel
    Hao, Ming-Hong
    Kroe, Rachel R.
    Liu, Pingrong
    Qian, Kevin C.
    Ralph, Mark
    Sarko, Christopher
    Soleymanzadeh, Fariba
    Moss, Nell
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (24) : 6316 - 6320
  • [47] Design, synthesis, biological evaluation, and in silico studies of quinoxaline derivatives as potent p38α MAPK inhibitors
    Anjali
    Kamboj, Payal
    Alam, Ozair
    Patel, Harun
    Ahmad, Iqrar
    Ahmad, Syed Sufian
    Amir, Mohd.
    ARCHIV DER PHARMAZIE, 2024, 357 (01)
  • [48] Discovery and Structure-Activity Relationships of N-Aryl 6-Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors
    Boutard, Nicolas
    Bialas, Arkadiusz
    Sabiniarz, Aleksandra
    Guzik, Pawel
    Banaszak, Katarzyna
    Biela, Artur
    Bien, Marcin
    Buda, Anna
    Bugaj, Barbara
    Cieluch, Ewelina
    Cierpich, Anna
    Dudek, Lukasz
    Eggenweiler, Hans-Michael
    Fogt, Joanna
    Gaik, Monika
    Gondela, Andrzej
    Jakubiec, Krzysztof
    Jurzak, Mirek
    Kitlinska, Agata
    Kowalczyk, Piotr
    Kujawa, Maciej
    Kwiecinska, Katarzyna
    Les, Marcin
    Lindemann, Ralph
    Maciuszek, Monika
    Mikulski, Maciej
    Niedziejko, Paulina
    Obara, Alicja
    Pawlik, Henryk
    Rzymski, Tomasz
    Sieprawska-Lupa, Magdalena
    Sowinska, Marta
    Szeremeta-Spisak, Joanna
    Stachowicz, Agata
    Tomczyk, Mateusz M.
    Wiklik, Katarzyna
    Wloszczak, Lukasz
    Ziemianska, Sylwia
    Zarebski, Adrian
    Brzozka, Krzysztof
    Nowak, Mateusz
    Fabritius, Charles-Henry
    CHEMMEDCHEM, 2019, 14 (01) : 169 - 181
  • [49] 5-cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38α MAP kinase
    Liu, CJ
    Wrobleski, ST
    Lin, J
    Ahmed, G
    Metzger, A
    Wityak, J
    Gillooly, KM
    Shuster, DJ
    McIntyre, KW
    Pitt, S
    Shen, DR
    Zhang, RF
    Zhang, HJ
    Doweyko, AM
    Diller, D
    Henderson, I
    Barrish, JC
    Dodd, JH
    Schieven, GL
    Leftheris, K
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (20) : 6261 - 6270
  • [50] The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors
    Cheung, Mui
    Harris, Philip A.
    Badiang, Jennifer G.
    Peckham, Gregory E.
    Chamberlain, Stanley D.
    Alberti, Michael J.
    Jung, David K.
    Harris, Stephanie S.
    Bramson, Neal H.
    Epperly, Andrea H.
    Stimpson, Stephen A.
    Peel, Michael R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5428 - 5430